New Oral Pill Could Revolutionize Diabetes Care

A breakthrough pill for type two diabetes could revolutionize treatment—no more needles or strict routines. Elecoglipron, an oral GLP-1 agonist, showed stunning results in a global trial: over 80% of patients hit blood sugar targets, and many lost meaningful weight. With a safety profile matching other GLP-1 drugs, this pill might finally make managing diabetes simple, effective, and accessible for millions. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/633c045c2a9c561f